Sex and gender in COVID-19 vaccines: data, policy, and communication

Stronger considerations of sex and gender factors in the COVID-19 vaccine R&D and data reporting process, policy decision-making, and science communication to the public can contribute to better science and innovation, and prevent avoidable harm in a timely manner. For this to happen, solidarity in commitment, cohesive practice, and open dialogue on the challenges and proposed solutions are imperative, so that sex and gender considerations are not ‘deprioritised’ in the current moment.